Close Menu

    Subscribe to Updates

    Get the latest news information from worldwide businesses.

    What's Hot

    Cerebras raises $5.5B, kicking off 2026’s IPO season with a bang

    May 14, 2026

    Faisal Islam: Why the UAE's exit from Opec is a big deal

    May 14, 2026

    Ukraine hit by second day of large-scale Russian missile and drone strikes | Ukraine

    May 14, 2026
    Facebook Instagram YouTube LinkedIn X (Twitter)
    Trending
    • Cerebras raises $5.5B, kicking off 2026’s IPO season with a bang
    • Faisal Islam: Why the UAE's exit from Opec is a big deal
    • Ukraine hit by second day of large-scale Russian missile and drone strikes | Ukraine
    • Ukraine tackles an arms-export puzzle
    • Kalyan Banerjee returns as Lok Sabha chief whip
    • Black Dahlia cold case detectives examine 1943 prints tied to ex-boyfriend
    • Anatomy of a NEET leak: A paid WhatsApp group, a whistleblower under cloud, and a ‘guess paper’ that spread like wildfire | Education News
    • Neil deGrasse Tyson serves up timely alien encounter advice in his latest book, ‘Take Me To Your Leader’ (interview)
    Newspublicly
    • About Us
    • Advertise & Partner with us
    • Pitch Your Story
    • Contact Us
    Facebook Instagram LinkedIn X (Twitter)
    Subscribe
    • Home
    • World News
      • Asia
      • India
      • USA
      • UK & Europe
      • Middle East
    • Economy & Business
      • Global Economy
      • Corporate & Industry
      • Finance & Markets
      • Policy & Trade
    • Technology
      • Gadgets & Devices
      • Software & Apps
      • AI & Machine Learning
      • Robotics & Automation
    • Health & Medicine
      • Fitness & Nutrition
      • Research & Innovation
      • Disease & Treatment
      • Doctors, Clinics & Patient Care
    • Travel & Tourism
    • Automobile
      • Electric & Hybrid Vehicles
      • Auto Industry Insights
    • Sports
    • More
      • Education
      • Real Estate
      • Environment & Climate
      • Space & Astronomy
      • War & Conflicts
    Newspublicly
    Home»Health & Medicine»Fitness & Nutrition»Nafisa Ali Sodhi switches chemotherapy drug after allergic reaction; experts explain why it happens
    Fitness & Nutrition

    Nafisa Ali Sodhi switches chemotherapy drug after allergic reaction; experts explain why it happens

    digitalixcomm@gmail.comBy digitalixcomm@gmail.comMay 14, 2026No Comments4 Mins Read0 Views
    Share
    Facebook Twitter LinkedIn Copy Link WhatsApp


    Nafisa Ali Sodhi, 69, who is currently battling a recurrence of stage 4 peritoneal and ovarian cancer, took to social media to apprise her followers about a change in her chemotherapy medication owing to an allergic reaction. “Last chemo (Friday) had to be stopped as I got allergic to it, so now … on a new chemo … to be taken once a week. Fighting the good fight,” Nafisa shared on Instagram.

    DISCLAIMER: This article is based on information from the public domain and/or the experts we spoke to. Always consult your health practitioner before starting any routine.

    Taking a cue from her revelation, we asked experts about why chemotherapy drugs and allergic reactions.

    Dr Jeyhan B. Dhabhar, a medical oncologist at the Head Neck Cancer Institute India (HNCII), said chemotherapy drugs are powerful medicines designed to attack cancer cells, but sometimes the body can react unexpectedly to them. “Allergic or hypersensitivity reactions to chemotherapy are not uncommon, especially with certain drugs that are given repeatedly over multiple treatment cycles,” said Dr Dhabhar.

    These reactions can range from mild symptoms such as itching, skin rashes, flushing, or breathlessness to more severe complications such as swelling, a sudden drop in blood pressure, chest tightness, or difficulty breathing. According to Dr Dhabhar, in many cases, the immune system begins to recognise the drug as a foreign substance and mounts an exaggerated response against it. “Interestingly, some patients tolerate a drug well initially and develop reactions only after several cycles of treatment,” he pointed out.

    The risk varies depending on the type of chemotherapy drug, the patient’s immune response, and prior exposure to the medication, said Dr Utkarsh Ajgaonkar, consultant surgical oncologist, TGH Onco Life Cancer Centre, Talegaon.

    doctor Here’s what you should consider (Photo: Getty Images/Thinkstock)

    At the same time, patients need to understand that modern chemotherapy is not simply about administering a drug.

    Story continues below this ad

    “A major part of cancer care involves carefully fine-tuning how chemotherapy is delivered. When chemotherapy is given by an experienced oncology team, with the correct drug dilution, appropriate infusion duration, proper monitoring, and the right supportive medications, many side effects can be significantly reduced,” said Dr Dhabhar.

    Dr Ajgaonkar too noted that in many cases, the patient is shifted to an “alternative chemotherapy plan” that is safer and better tolerated. “Cancer treatment today is highly personalised, and specialists work closely to balance effectiveness with patient safety and comfort. Patients should immediately report any unusual symptoms during or after chemotherapy so that timely action can be taken,” said Dr Ajgaonkar.

    Pre-medications — which are medicines and injections given before chemotherapy — play a crucial role in preventing allergic reactions, nausea, vomiting, oral ulcers, acidity, and several immediate side effects associated with treatment. “Similarly, post-chemotherapy medications prescribed for home use help patients recover better and minimise delayed side effects after the infusion. The timing, dosage, and combination of these supportive medicines are extremely important in improving tolerance to treatment.”

     

     

    The reassuring part is that an allergic reaction to one chemotherapy drug does not mean cancer treatment has reached a dead end, he asserted. “Modern oncology offers several alternatives and ways to safely continue treatment. Depending on the patient’s cancer type, overall condition, and prior response, oncologists may switch to another chemotherapy agent, modify the dosage, reduce the infusion speed, or shift to a weekly regimen that may be better tolerated.”

    Story continues below this ad

    Cancer treatment is rarely a completely linear journey, he noted. “It often requires adjustments and fine-tuning based on how the patient’s body responds over time. What is most important is close monitoring and prompt reporting of symptoms during chemotherapy sessions. Signs such as sudden itching, dizziness, chest discomfort, or breathing difficulty should immediately alert the medical team so intervention can happen early.”

    With advances in medical oncology, treatment today is highly personalised. “Even when one drug has to be stopped, there are usually multiple effective alternatives available, allowing patients to continue their cancer treatment safely and meaningfully,” said Dr Dhabhar.





    Source link

    Author

    • digitalixcomm@gmail.com

      NewsPublicly.com is News & Articles Platform that creating SEO-focused articles on travel, lifestyle, and digital trends.

    digitalixcomm@gmail.com
    • Website

    NewsPublicly.com is News & Articles Platform that creating SEO-focused articles on travel, lifestyle, and digital trends.

    Related Posts

    Can eating eggs five times a week cut down Alzheimer’s risk?

    May 14, 2026

    Why Japan’s everyday lifestyle may be the key to longer life | Health News

    May 14, 2026

    Salt in Every Glass? Why Experts Warn Against This Viral Hydration Hack

    May 14, 2026
    Leave A Reply Cancel Reply

    Demo
    Top Posts

    “Inside Gemini Robotics 1.5: How Robots Learn to Reason & Act

    November 22, 202524 Views

    How US Tariffs Are Reshaping the Global Growth Landscape?

    November 21, 202518 Views

    Pakistani Journalist Laughing at Tejas Fighter Jet Crash at Dubai Airshow Sparks Massive Outrage Worldwide

    November 23, 202517 Views

    Vibe-Coding Boom: How Non-Coders Build Apps With AI Agents

    November 22, 202515 Views
    Don't Miss

    Cerebras raises $5.5B, kicking off 2026’s IPO season with a bang

    May 14, 20262 Mins Read0 Views

    Cerebras raised $5.5 billion in its IPO on Thursday, pricing shares at $185 Wednesday evening,…

    Faisal Islam: Why the UAE's exit from Opec is a big deal

    May 14, 2026

    Ukraine hit by second day of large-scale Russian missile and drone strikes | Ukraine

    May 14, 2026

    Ukraine tackles an arms-export puzzle

    May 14, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • LinkedIn
    • WhatsApp

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Demo
    NEWSPUBLICLY
    Facebook X (Twitter) Instagram LinkedIn

    Home

    • About Us
    • Leadership
    • Advertise & Partner With Us
    • Pitch Your Story
    • Media Kit & Pricing
    • Career
    • FAQs

    Guidelines

    • Editorial & Submission
    • Partnership
    • Advertising & Sponsor
    • Intellectual Property Policy
    • Community & Comment
    • Security & Data Protection
    • Send Your Opinion

    Quick Links

    • Cookie Policy
    • Payment & Billing Terms
    • Refund & Cancellation
    • Copyright Policy
    • Complaint & Support
    • Sitemap
    • Contact Us

    Subscribe Us

    Get the latest news and updates!

    Copyright © 2026 Newspublicly (DIGITALIX COMMUNICATION). All Rights Reserved.
    • Privacy Policy
    • Terms of Use
    • Disclaimer